Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’
Top Cited Papers
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (1) , 134-146
- https://doi.org/10.1016/s0168-8278(01)00092-7
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled studyJournal of Hepatology, 1998
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosisJournal of Hepatology, 1996
- Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosisDigestive Diseases and Sciences, 1996
- Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodJournal of Hepatology, 1994
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993
- Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1990
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Ursodeoxycholic acid in the treatment of cholesterol cholelithiasisDigestive Diseases and Sciences, 1982